A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues Yan Gu; Yao Zhang; Zhiyi Zhang; Jian Wang; Qing Zhang; Shaoqiu Zhang; Yilin Liu; Jiacheng Liu; Juan Xia; Xiaomin Yan; Jie Li; Xingxiang Liu; Rui Huang; Chao Wu;

Consensus document on acute-on-chronic liver failure (ACLF) established by the Mexican Association of Hepatology Aldo Torre; Laura Esthela Cisneros-Garza; Mauricio Castillo-Barradas; Nalu Navarro-Alvarez; Ricardo Sandoval-Salas; María Sarai González-Huezo; José Luís Pérez-Hernández; Osvely Méndez-Guerrero; Jesús Alejandro Ruiz-Manríquez; Rafael Trejo-Estrada; Norberto C. Chavez-Tapia; Luis Carlos Solís-Gasca; Carlos Moctezuma-Velázquez; Jonathan Aguirre-Valádez; Judith Flores-Calderón; Fatima Higuera-de-la-Tijera; Ignacio García-Juárez; Nancy Allin Canedo-Castillo; René Malé-Velázquez; Iaarah Montalvo-Gordon; Mario Vilatobá; Ernesto Márquez-Guillén; Jacqueline Córdova-Gallardo; Nayeli Cointa Flores-García; Godolfino Miranda-Zazueta; Belinda Isela Martínez-Saldívar; Víctor Manuel Páez-Zayas; Linda Elsa Muñoz-Espinosa; Francisco Alfonso Solís-Galindo;

Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir Fa- Da Wang; Jing Zhou; Lan-Qing Li; Yu-Jing Li; Meng-Lan Wang; Ya-Chao Tao; Dong-Mei Zhang; Yong-Hong Wang; En-Qiang Chen;